Per ulteriori informazioni selezionare i riferimenti di interesse.
Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracilin previously treated patients with advanced ovarian cancer: Long-term follow-up
Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up
INCIDENCE OF CHROMOSOME NUMERICAL CHANGES IN MULTIPLE-MYELOMA - FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS USING 15 CHROMOSOME-SPECIFIC PROBES
The American journal of pathology